Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MYHIBBIN safely and effectively. See full prescribing information for MYHIBBIN. MYHIBBIN®(mycophenolate mofetil oral suspension) Initial U.S. Approval: 1995
Medication labelWhy this: Advisory · dailymed-prescription
MYHIBBIN is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1)], heart [see Clinical Studies (14.2)] or liver transplants [see Clinical Studies (14.3)], in combination with other immunosuppressants.
- generic_name
- mycophenolate mofetil
- product_names
- MYCOPHENOLATE MOFETIL
- ndc
- 24338-018, 24338-018-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en